Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells

Author:

Abumanhal-Masarweh Hanan,da Silva Dana,Poley MariaORCID,Zinger Assaf,Goldman Evgenya,Krinsky Nitzan,Kleiner Ron,Shenbach Gal,Schroeder Josh E.,Shklover Jeny,Shainsky-Roitman Janna,Schroeder AviORCID

Funder

ERC

Technion Integrated Cancer Center

the Russell Berrie Nanotechnology Institute

the Lorry I. Lokey Interdisciplinary Center for Life Sciences & Engineering

The Israel Ministry of Economy for a Kamin Grant

the Israel Ministry of Science Technology and Space – Office of the Chief Scientist

the Israel Science Foundation

the Israel Cancer Association

the German-Israeli Foundation for Scientific Research and Development

European Union FP-7 IRG Program for a Career Integration Grant

the Phospholipid Research Center Grant

a Mallat Family Foundation Grant

The Unger Family Fund

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference91 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J. Clin.,2016

2. Triple-negative breast cancer: role of specific chemotherapy agents;Isakoff;Cancer J.,2010

3. Treating metastatic cancer with nanotechnology;Schroeder;Nature Rev. Cancer,2011

4. Nanocarriers as an emerging platform for cancer therapy;Peer;Nat. Nanotechnol.,2007

5. Nanomedicine(s) under the microscope;Duncan;Mol. Pharm.,2011

Cited by 67 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3